<DOC>
	<DOCNO>NCT00139867</DOCNO>
	<brief_summary>The objective trial ass subject preference PARCOPA , carbidopa/levodopa Orally Disintegrating Tablets ( ODT ) , compare conventional carbidopa/levodopa tablet , subject stable Parkinson 's disease .</brief_summary>
	<brief_title>A Multicenter , Open-label Trial Assess Subject Preference PARCOPA , Carbidopa/Levodopa Orally Disintegrating Tablets , Compared Conventional Carbidopa/Levodopa Tablets Subjects With Stable Parkinson 's Disease</brief_title>
	<detailed_description>See approve Package Insert Adverse Event information .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<mesh_term>Carbidopa , levodopa drug combination</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Stable Parkinson 's Disease Not use carbidopa/levodopa tablet</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>